Search

Your search keyword '"Storey, Robert"' showing total 1,879 results
Start Over Author "Storey, Robert"
1,879 results on '"Storey, Robert"'

155. Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54

Author

Bonaca, Marc P., Bhatt, Deepak L., Steg, P. Gabriel, Storey, Robert F., Cohen, Marc, Im, Kyungah, Oude Ophuis, Ton, Budaj, Andrej, Goto, Shinya, López-Sendón, José, Diaz, Rafael, Dalby, Anthony, Van de Werf, Frans, Ardissino, Diego, Montalescot, Gilles, Aylward, Philip, Magnani, Giulia, Jensen, Eva C., Held, Peter, Braunwald, Eugene, and Sabatine, Marc S.

Published
2016
Full Text
View/download PDF

157. Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial

Author

Magnani, Giulia, Storey, Robert F., Steg, Gabriel, Bhatt, Deepak L., Cohen, Marc, Kuder, Julia, Im, Kyungah, Aylward, Philip, Ardissino, Diego, Isaza, Daniel, Parkhomenko, Alexander, Goudev, Assen R., Dellborg, Mikael, Kontny, Frederic, Corbalan, Ramon, Medina, Felix, Jensen, Eva C., Held, Peter, Braunwald, Eugene, Sabatine, Marc S., and Bonaca, Marc P.

Published
2016
Full Text
View/download PDF

158. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)

Author

Roffi, Marco, Patrono, Carlo, Collet, Jean-Philippe, Mueller, Christian, Valgimigli, Marco, Andreotti, Felicita, Bax, Jeroen J., Borger, Michael A., Brotons, Carlos, Chew, Derek P., Gencer, Baris, Hasenfuss, Gerd, Kjeldsen, Keld, Lancellotti, Patrizio, Landmesser, Ulf, Mehilli, Julinda, Mukherjee, Debabrata, Storey, Robert F., Windecker, Stephan, Baumgartner, Helmut, Gaemperli, Oliver, Achenbach, Stephan, Agewall, Stefan, Badimon, Lina, Baigent, Colin, Bueno, Héctor, Bugiardini, Raffaele, Carerj, Scipione, Casselman, Filip, Cuisset, Thomas, Erol, Çetin, Fitzsimons, Donna, Halle, Martin, Hamm, Christian, Hildick-Smith, David, Huber, Kurt, Iliodromitis, Efstathios, James, Stefan, Lewis, Basil S., Lip, Gregory Y. H., Piepoli, Massimo F., Richter, Dimitrios, Rosemann, Thomas, Sechtem, Udo, Steg, Ph. Gabriel, Vrints, Christian, and Luis Zamorano, Jose

Published
2016
Full Text
View/download PDF

159. Complete Revascularization vs Culprit Lesion–Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial.

Author

Mehta, Shamir R., Wang, Jia, Wood, David A., Spertus, John A., Cohen, David J., Mehran, Roxana, Storey, Robert F., Steg, Philippe Gabriel, Pinilla-Echeverri, Natalia, Sheth, Tej, Bainey, Kevin R., Bangalore, Sripal, Cantor, Warren J., Faxon, David P., Feldman, Laurent J., Jolly, Sanjit S., Kunadian, Vijay, Lavi, Shahar, Lopez-Sendon, Jose, and Madan, Mina

Published
2022
Full Text
View/download PDF

162. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

Author

Cannon, Christopher P, Harrington, Robert A, James, Stefan, Ardissino, Diego, Becker, Richard C, Emanuelsson, Håkan, Husted, Steen, Katus, Hugo, Keltai, Matyas, Khurmi, Nardev S, Kontny, Frederic, Lewis, Basil S, Steg, Philippe Gabriel, Storey, Robert F, Wojdyla, Daniel, and Wallentin, Lars

Published
2010
Full Text
View/download PDF

163. Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions: Antithrombotic drugs in bifurcation PCI

Author

Zimarino, Marco, Angiolillo, Dominick J., Dangas, George, Capodanno, Davide, Barbato, Emanuele, Hahn, Joo-Yong, Rossini, Roberta, Sibbing, Dirk, Burzotta, Francesco, Louvard, Yves, Shehab, Abdulla, Renda, Giulia, Kimura, Takeshi, Gwon, Hyeon-Cheol, Chen, Shao-Liang, Costa, Ricardo, Koo, Bon-Kwon, Storey, Robert, Valgimigli, Marco, Mehran, Roxana, and Stankovic, Goran

Subjects
Europe, Asia, Percutaneous Coronary Intervention, Treatment Outcome, Fibrinolytic Agents, Humans, Coronary Artery Disease, Expert Review, Platelet Aggregation Inhibitors
Abstract

Coronary bifurcations exhibit localised turbulent flow and an enhanced propensity for atherothrombosis, platelet deposition and plaque rupture. Percutaneous coronary intervention (PCI) of bifurcation lesions is associated with an increased risk of thrombotic events. Such risk is modulated by anatomical complexity, intraprocedural factors and pharmacological therapy. There is no consensus on the appropriate PCI strategy or the optimal regimen and duration of antithrombotic treatment in order to decrease the risk of ischaemic and bleeding complications in the setting of coronary bifurcation. A uniform therapeutic approach meets a clinical need. The present initiative, promoted by the European Bifurcation Club (EBC), involves opinion leaders from Europe, America, and Asia with the aim of analysing the currently available evidence. Although mainly derived from small dedicated studies, substudies of large trials or from authors' opinions, an algorithm for the optimal management of patients undergoing bifurcation PCI, developed on the basis of clinical presentation, bleeding risk, and intraprocedural strategy, is proposed here.

Published
2021

164. Early computed tomography coronary angiography in patients with suspected acute coronary syndrome: randomised controlled trial

Author

Gray, Alasdair J, primary, Roobottom, Carl, additional, Smith, Jason E, additional, Goodacre, Steve, additional, Oatey, Katherine, additional, O’Brien, Rachel, additional, Storey, Robert F, additional, Curzen, Nick, additional, Keating, Liza, additional, Kardos, Attila, additional, Felmeden, Dirk, additional, Lee, Robert J, additional, Thokala, Praveen, additional, Lewis, Steff C, additional, and Newby, David E, additional

Published
2021
Full Text
View/download PDF

165. Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events

Author

Cubedo, Judit, primary, Padró, Teresa, additional, Vilahur, Gemma, additional, Crea, Filippo, additional, Storey, Robert F, additional, Lopez Sendon, Jose Luis, additional, Kaski, Juan Carlos, additional, Sionis, Alessandro, additional, Sans-Rosello, Jordi, additional, Fernández-Peregrina, Estefanía, additional, Gallinat, Alex, additional, and Badimon, Lina, additional

Published
2021
Full Text
View/download PDF

166. Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial

Author

Bergmark, Brian A., primary, Bhatt, Deepak L., additional, Steg, P. Gabriel, additional, Budaj, Andrzej, additional, Storey, Robert F., additional, Gurmu, Yared, additional, Kuder, Julia F., additional, Im, KyungAh, additional, Magnani, Giulia, additional, Oude Ophuis, Ton, additional, Hamm, Christian, additional, Špinar, Jindřich, additional, Kiss, Robert G., additional, Van de Werf, Frans J., additional, Montalescot, Gilles, additional, Johanson, Per, additional, Braunwald, Eugene, additional, Sabatine, Marc S., additional, and Bonaca, Marc P., additional

Published
2021
Full Text
View/download PDF

173. Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial

Author

Tomaniak, Mariusz, Chichareon, Ply, Onuma, Yoshinobu, Deliargyris, Efthymios N., Takahashi, Kuniaki, Kogame, Norihiro, Modolo, Rodrigo, Chang, Chun Ching, Rademaker-Havinga, Tessa, Storey, Robert F., Dangas, George D., Bhatt, Deepak L., Angiolillo, Dominick J., Hamm, Christian, Valgimigli, Marco, Windecker, Stephan, Steg, Philippe Gabriel, Vranckx, Pascal, Serruys, Patrick W., Bertrand, Olivier F., Plante, Sylvain, Van Geuns, Robert-Jan, Hofma, Sjoerd H., Royaards, Kees-Jan, Slagboom, Ton, Suryapranata, Harry, Umans, Victor A. W. M., Rensing, Benno, van der Harst, Pim, Magro, Michael, Barbato, Emanuel, Aminian, Adel, Benit, Edouard, Janssens, Luc, Vrolix, Mathias, Buysschaert, Ian, Carrie, Didier, Barraud, Pascal, Teiger, Emmanuel, Koning, Ren, Farzin, Beygui, Morelle, Jean-francois, Isaaz, Karl, Maillard, Luc, Abdellaoui, Mohamed, Brunel, Philippe, Angioi, Michael, Lantelme, Pierre, Sabate, Manel, Albarran Gonzalez-Trevilla, Agustin, Cardiology, Graduate School, ACS - Atherosclerosis & ischemic syndromes, ACS - Microcirculation, ACS - Heart failure & arrhythmias, and Cardiovascular Centre (CVC)

Subjects
Male, Ticagrelor, Internationality, Time Factors, medicine.medical_treatment, 030204 cardiovascular system & hematology, Severity of Illness Index, Tertiary Care Centers, Coronary artery disease, 0302 clinical medicine, Cause of Death, 030212 general & internal medicine, 610 Medicine & health, Original Investigation, Aspirin, DUAL ANTIPLATELET THERAPY, Continuity of Patient Care, Clopidogrel, Treatment Outcome, CLOPIDOGREL, Platelet aggregation inhibitor, Drug Therapy, Combination, Female, Cardiology and Cardiovascular Medicine, INTERVENTION, medicine.drug, Acute coronary syndrome, medicine.medical_specialty, Hemorrhage, Risk Assessment, Drug Administration Schedule, 03 medical and health sciences, Percutaneous Coronary Intervention, Internal medicine, medicine, Humans, Acute Coronary Syndrome, Dose-Response Relationship, Drug, RECEPTOR, business.industry, Percutaneous coronary intervention, IN-VITRO, medicine.disease, Survival Analysis, PLATO, Conventional PCI, business, Platelet Aggregation Inhibitors, Follow-Up Studies
Abstract

Key PointsQuestionWhat are the benefits and risks of continuing aspirin in addition to P2Y12 receptor inhibition with ticagrelor among patients with acute coronary syndrome between 1 month and 12 months after percutaneous coronary intervention? FindingsIn this nonprespecified, post hoc analysis of the GLOBAL LEADERS randomized clinical trial, beyond 1 month after percutaneous coronary intervention in acute coronary syndrome, aspirin was associated with increased bleeding risk and appeared not to add to the benefit of ticagrelor on ischemic events. MeaningThe findings of this hypothesis-generating analysis pave the way for further trials evaluating aspirin-free antiplatelet strategies after percutaneous coronary intervention.ImportanceThe role of aspirin as part of antiplatelet regimens in acute coronary syndromes (ACS) needs to be clarified in the context of newer potent P2Y12 antagonists. ObjectiveTo evaluate the benefit and risks of aspirin in addition to ticagrelor among patients with ACS beyond 1 month after percutaneous coronary intervention (PCI). Design, Setting, and ParticipantsThis is a nonprespecified, post hoc analysis of GLOBAL LEADERS, a randomized, open-label superiority trial comparing 2 antiplatelet treatment strategies after PCI. The trial included 130 secondary/tertiary care hospitals in different countries, with 15991 unselected patients with stable coronary artery disease or ACS undergoing PCI. Patients had outpatient visits at 1, 3, 6, 12, 18, and 24 months after index procedure. InterventionsThe experimental group received aspirin plus ticagrelor for 1 month followed by 23-month ticagrelor monotherapy; the reference group received aspirin plus either clopidogrel (stable coronary artery disease) or ticagrelor (ACS) for 12 months, followed by 12-month aspirin monotherapy. In this analysis, we examined the clinical outcomes occurring between 31 days and 365 days after randomization, specifically in patients with ACS who, within this time frame, were assigned to receive either ticagrelor alone or ticagrelor and aspirin. Main Outcomes and MeasuresThe primary outcome was the composite of all-cause death or new Q-wave myocardial infarction. ResultsOf 15968 participants, there were 7487 patients with ACS enrolled; 3750 patients were assigned to the experimental group and 3737 patients to the reference group. Between 31 and 365 days after randomization, the primary outcome occurred in 55 patients (1.5%) in the experimental group and in 75 patients (2.0%) in the reference group (hazard ratio [HR], 0.73; 95% CI, 0.51-1.03; P=.07); investigator-reported Bleeding Academic Research Consortium-defined bleeding type 3 or 5 occurred in 28 patients (0.8%) in the experimental group and in 54 patients (1.5%) in the reference arm (HR, 0.52; 95% CI, 0.33-0.81; P=.004). Conclusions and RelevanceBetween 1 month and 12 months after PCI in ACS, aspirin was associated with increased bleeding risk and appeared not to add to the benefit of ticagrelor on ischemic events. These findings should be interpreted as exploratory and hypothesis generating; however, they pave the way for further trials evaluating aspirin-free antiplatelet strategies after PCI. Trial RegistrationClinicalTrials.gov identifier: NCT01813435.This secondary analysis of the GLOBAL LEADERS randomized clinical trial evaluates the benefit and risks of aspirin in addition to ticagrelor among patients with acute coronary syndrome beyond 1 month after percutaneous coronary intervention.

Published
2019

178. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

Author

Bonaca, Marc P., Bhatt, Deepak L., Cohen, Marc, Steg, Philippe Gabriel, Storey, Robert F., Jensen, Eva C., Magnani, Giulia, Bansilal, Sameer, Fish, M. Polly, Im, Kyungah, Bengtsson, Olof, Ophuis, Ton Oude, Budaj, Andrzej, Theroux, Pierre, Ruda, Mikhail, Hamm, Christian, Goto, Shinya, Spinar, Jindrich, Nicolau, José Carlos, Kiss, Robert G., Murphy, Sabina A., Wiviott, Stephen D., Held, Peter, Braunwald, Eugene, and Sabatine, Marc S.

Published
2015
Full Text
View/download PDF

179. Expert position paper on air pollution and cardiovascular disease

Author

Newby, David E., Mannucci, Pier M., Tell, Grethe S., Baccarelli, Andrea A., Brook, Robert D., Donaldson, Ken, Forastiere, Francesco, Franchini, Massimo, Franco, Oscar H., Graham, Ian, Hoek, Gerard, Hoffmann, Barbara, Hoylaerts, Marc F., Künzli, Nino, Mills, Nicholas, Pekkanen, Juha, Peters, Annette, Piepoli, Massimo F., Rajagopalan, Sanjay, and Storey, Robert F.

Published
2015
Full Text
View/download PDF

181. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Author

Collet, Jean-Philippe, Thiele, Holger, Barbato, Emanuele, Barthélémy, Olivier, Bauersachs, Johann, Bhatt, Deepak, Dendale, Paul, Dorobantu, Maria, Edvardsen, Thor, Folliguet, Thierry, Gale, Chris, Gilard, Martine, Jobs, Alexander, Jüni, Peter, Lambrinou, Ekaterini, Lewis, Basil, Mehilli, Julinda, Meliga, Emanuele, Merkely, Béla, Mueller, Christian, Roffi, Marco, Rutten, Frans, Sibbing, Dirk, Siontis, George, Kastrati, Adnan, Mamas, Mamas, Aboyans, Victor, Angiolillo, Dominick, Bueno, Hector, Bugiardini, Raffaele, Byrne, Robert, Castelletti, Silvia, Chieffo, Alaide, Cornelissen, Veronique, Crea, Filippo, Delgado, Victoria, Drexel, Heinz, Gierlotka, Marek, Halvorsen, Sigrun, Haugaa, Kristina Hermann, Jankowska, Ewa, Katus, Hugo, Kinnaird, Tim, Kluin, Jolanda, Kunadian, Vijay, Landmesser, Ulf, Leclercq, Christophe, Lettino, Maddalena, Meinila, Leena, Mylotte, Darren, Ndrepepa, Gjin, Omerovic, Elmir, Pedretti, Roberto, Petersen, Steffen, Petronio, Anna Sonia, Pontone, Gianluca, Popescu, Bogdan, Potpara, Tatjana, Ray, Kausik, Luciano, Flavio, Richter, Dimitrios, Shlyakhto, Evgeny, Simpson, Iain, Sousa-Uva, Miguel, Storey, Robert, Touyz, Rhian, Valgimigli, Marco, VRANCKX, PASCAL, Yeh, Robert, Collet, Jean-Philippe, Thiele, Holger, Barbato, Emanuele, Barthélémy, Olivier, Bauersachs, Johann, Bhatt, Deepak L, Dendale, Paul, Dorobantu, Maria, Edvardsen, Thor, Folliguet, Thierry, Gale, Chris P, Gilard, Martine, Jobs, Alexander, Jüni, Peter, Lambrinou, Ekaterini, Lewis, Basil S, Mehilli, Julinda, Meliga, Emanuele, Merkely, Béla, Mueller, Christian, Roffi, Marco, Rutten, Frans H, Sibbing, Dirk, Siontis, George C M, Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut de cardiologie [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Collet J.-P., Thiele H., Barbato E., Bauersachs J., Dendale P., Edvardsen T., Gale C.P., Jobs A., Lambrinou E., Mehilli J., Merkely B., Roffi M., Sibbing D., Kastrati A., Mamas M.A., Aboyans V., Angiolillo D.J., Bueno H., Bugiardini R., Byrne R.A., Castelletti S., Chieffo A., Cornelissen V., Crea F., Delgado V., Drexel H., Gierlotka M., Halvorsen S., Haugaa K.H., Jankowska E.A., Katus H.A., Kinnaird T., Kluin J., Kunadian V., Landmesser U., Leclercq C., Lettino M., Meinila L., Mylotte D., Ndrepepa G., Omerovic E., Pedretti R.F.E., Petersen S.E., Petronio A.S., Pontone G., Popescu B.A., Potpara T., Ray K.K., Luciano F., Richter D.J., Shlyakhto E., Simpson I.A., Sousa-Uva M., Storey R.F., Touyz R.M., Valgimigli M., Vranckx P., Yeh R.W., Barthelemy O., Bhatt D.L., Dorobantu M., Folliguet T., Gilard M., Juni P., Lewis B.S., Meliga E., Mueller C., Rutten F.H., and Siontis G.C.M.

Subjects
unstable angina, Myocardial ischaemia, [SDV]Life Sciences [q-bio], Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], dual antithrombotic therapy, Guideline, heparin, 030204 cardiovascular system & hematology, Platelet inhibition, antiplatelet, 0302 clinical medicine, ST segment, Medicine, dabigatran, Myocardial infarction, guidelines, glycoprotein iib/iiia inhibitors, anticoagulation, Non-ST Elevated Myocardial Infarction, rivaroxaban, ComputingMilieux_MISCELLANEOUS, reproductive and urinary physiology, diabetes, bleedings, bivalirudin, atherothrombosi, Disease Management, angioplasty, Guidelines • acute cardiac care • acute coronary syndrome • angioplasty • anticoagulation • antiplatelet • apixaban • aspirin • atherothrombosis • betablockers • bleedings • bivalirudin • bypass surgery • cangrelor • chest pain unit • clopidogrel • dabigatran • diabetes • dual antithrombotic therapy • early invasive strategy • edoxaban • enoxaparin • European Society of Cardiology • fondaparinux • glycoprotein IIb/ IIIa inhibitors • heparin • high-sensitivity troponin • minoca • myocardial ischaemia • myocardial infarction • nitrates • non-ST-elevation myocardial infarction • platelet inhibition • prasugrel • recommendations • revascularization • rhythm monitoring • rivaroxaban • stent • ticagrelor • triple therapy • unstable angina, enoxaparin, General Medicine, Clopidogrel, 3. Good health, early invasive strategy, myocardial infarction, triple therapy, 030220 oncology & carcinogenesis, High sensitivity troponin, embryonic structures, Cardiology, Platelet aggregation inhibitor, revascularization, biological phenomena, cell phenomena, and immunity, Cardiology and Cardiovascular Medicine, Ticagrelor, medicine.drug, Human, recommendation, Acute coronary syndrome, medicine.medical_specialty, aspirin, glycoprotein IIb/IIIa inhibitor, non-ST-elevation myocardial infarction, apixaban, rhythm monitoring, European Society of Cardiology, ticagrelor, 03 medical and health sciences, nitrate, atherothrombosis, betablockers, Internal medicine, acute cardiac care, minoca, chest pain unit, Diseases of the circulatory (Cardiovascular) system, Humans, In patient, Acute Coronary Syndrome, clopidogrel, Unstable angina, urogenital system, nitrates, business.industry, fondaparinux, betablocker, Arrhythmias, Cardiac, 030229 sport sciences, bleeding, medicine.disease, myocardial ischaemia, platelet inhibition, prasugrel, diabete, Glycoprotein IIb/IIIa inhibitors, RC666-701, bypass surgery, Settore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE, recommendations, edoxaban, high-sensitivity troponin, stent, business, Platelet Aggregation Inhibitors, cangrelor
Abstract

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Published
2021
Full Text
View/download PDF

183. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

Author

Lip, Gregory Y.H., Windecker, Stephan, Huber, Kurt, Kirchhof, Paulus, Marin, Francisco, Ten Berg, Jurriën M., Haeusler, Karl Georg, Boriani, Giuseppe, Capodanno, Davide, Gilard, Martine, Zeymer, Uwe, Lane, Deirdre, Storey, Robert F., Bueno, Hector, Collet, Jean-Philippe, Fauchier, Laurent, Halvorsen, Sigrun, Lettino, Maddalena, Morais, Joao, Mueller, Christian, Potpara, Tatjana S., Rasmussen, Lars Hvilsted, Rubboli, Andrea, Tamargo, Juan, Valgimigli, Marco, and Zamorano, Jose L.

Published
2014
Full Text
View/download PDF

192. Section of Individual Rights and Responsibilities Monograph no.3

Author

Shestack, Jerome J., Burger, Warren E., Fordham, Jefferson B., Cox, Kenneth A., Daniel, Clifton, Jencks, Richard W., Dickinson, William B., Dunham, Corydon B., Walker, Daniel, Cutler, Lloyd N., Wilson, Will R., Clark, Ramsey, Bodner, John, Santarelli, Donald, Roberts, Samuel J., Storey, Robert G., Hauser, Rita E., Kadish, Sanford H., Kadish, Stanford H., Debevoise, Eli Whitney, Rhyne, Charles S., Poole, Cecil F., Sovern, Michael I., Glazer, Nathan, Lowenstein, Allard K., Cahn, Jean Camper, Van Alstyne, William, and Willan, Robert

Published
1969

193. Section of Individual Rights and Responsibilities Monograph no.1

Author

FORDHAM, JEFFERSON B., Pollak, Louis H., Griswold, Erwin N., Spann,, William B., Ortique,, Revius O., Judd, Orrin G., Storey, Robert G., Greenberg, Jack, Poole, Cecil F., Miller, Ben R., Miller, Been R., Rachlin, Carl, Cutler, Lloyd N., Edwards,, George Clifton, Dash, Samuel, Zwick, Charles J., Lumbard, J. Edward, Kamisar, Yale, and Kayton, Irving

Published
1967

194. Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy

Author

Nelson, Thomas A., primary, Parker, William A.E., additional, Ghukasyan Lakic, Tatevik, additional, Westerbergh, Johan, additional, James, Stefan K., additional, Siegbahn, Agneta, additional, Becker, Richard C., additional, Himmelmann, Anders, additional, Wallentin, Lars, additional, and Storey, Robert F., additional

Published
2021
Full Text
View/download PDF

196. Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions

Author

Zimarino, Marco, primary, Angiolillo, Dominick J., additional, Dangas, George, additional, Capodanno, Davide, additional, Barbato, Emanuele, additional, Hahn, Joo-Yong, additional, Giustino, Gennaro, additional, Watanabe, Hirotsohi, additional, Costa, Francesco, additional, Cuisset, Thomas, additional, Rossini, Roberta, additional, Sibbing, Dirk, additional, Burzotta, Francesco, additional, Louvard, Yves, additional, Shehab, Abdulla, additional, Renda, Giulia, additional, Kimura, Takeshi, additional, Gwon, Hyeon-Cheol, additional, Chen, Shao-Liang, additional, Costa, Ricardo A., additional, Koo, Bon-Kwon, additional, Storey, Robert F., additional, Valgimigli, Marco, additional, Mehran, Roxana, additional, and Stankovic, Goran, additional

Published
2021
Full Text
View/download PDF

197. COMPLETE REVASCULARIZATION IN PATIENTS UNDERGOING A PHARMACOINVASIVE STRATEGY FOR STEMI

Author

Dehghani, Payam, primary, Cantor, Warren, additional, Wang, Jia, additional, Wood, David, additional, Storey, Robert, additional, Mehran, Roxana, additional, Bainey, Kevin, additional, Welsh, Robert, additional, Rodes-Cabau, Josep, additional, Rao, Sunil, additional, Lavi, Shahar, additional, Velianou, James, additional, Natarajan, Madhu, additional, Ziakas, Antonios, additional, Guiducci, Vincenzo, additional, Aviles, Francisco Fernandez, additional, Cairns, John, additional, and Mehta, Shamir, additional

Published
2021
Full Text
View/download PDF

200. Supplement to: Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

Author

Tricoci, Pierluigi, Huang, Zhen, Held, Claes, Moliterno, David J., Armstrong, Paul W., Van de Werf, Frans, White, Harvey D., Aylward, Philip E., Wallentin, Lars, Chen, Edmond, Lokhnygina, Yuliya, Pei, Jinglan, Leonardi, Sergio, Rorick, Tyrus L., Kilian, Ann M., Jennings, Lisa H.K., Ambrosio, Giuseppe, Bode, Christoph, Cequier, Angel, Cornel, Jan H., Diaz, Rafael, Erkan, Aycan, Huber, Kurt, Hudson, Michael P., Jiang, Lixin, Jukema, Wouter J., Lewis, Basil S., Lincoff, Michael A., Montalescot, Gilles, Nicolau, José Carlos, Ogawa, Hisao, Pfisterer, Matthias, Prieto, Juan Carlos, Ruzyllo, Witold, Sinnaeve, Peter R., Storey, Robert F., Valgimigli, Marco, Whellan, David J., Widimsky, Petr, Strony, John, Harrington, Robert A., and Mahaffey, Kenneth W.

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results